Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
Ahmed M Elsharkawy, Lobna Al Zaidan, Ahmed Malki
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Pathogens Hijack Host Cell Metabolism: Intracellular Infection as a Driver of the Warburg Effect in Cancer and Other Chronic Inflammatory Conditions
Amy D. Proal, Michael B. VanElzakker
Immunometabolism (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 23
The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis
Javad Charostad, Mohsen Nakhaie, Arezo Dehghani, et al.
Infectious Agents and Cancer (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Epstein–Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells
Tomonori Higuchi, Kazuhiko Matsuo, Yumiko Hashida, et al.
Cancer Letters (2019) Vol. 453, pp. 184-192
Closed Access | Times Cited: 20
Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
Flavia Zita Francies, Zodwa Dlamini
Cells (2021) Vol. 10, Iss. 2, pp. 239-239
Open Access | Times Cited: 17
Pathogenesis and therapeutic implications of EBV-associated epithelial cancers
Yi Hua Low, Celestine Jia Ling Loh, Daniel Yang Yao Peh, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Hitting Epstein Barr virus where it hurts: computational methods exploration for siRNA therapy in alleviating Epstein Barr virus-induced multiple sclerosis
Taiwo Ooreoluwa Ojo, Oluwabamise Emmanuel Elegbeleye, Olawale Quadri Bolaji, et al.
Neurogenetics (2024) Vol. 25, Iss. 3, pp. 263-275
Closed Access | Times Cited: 2
Aspirin Inhibits Natural Killer/T-Cell Lymphoma by Modulation of VEGF Expression and Mitochondrial Function
Hongyu Zhang, Jianping Lu, Yun Jiao, et al.
Frontiers in Oncology (2019) Vol. 8
Open Access | Times Cited: 18
Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL
Stefan Nagel, Cord C. Uphoff, Wilhelm G. Dirks, et al.
PLoS ONE (2019) Vol. 14, Iss. 5, pp. e0216898-e0216898
Open Access | Times Cited: 18
Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
Krzysztof Wojtak, Alfredo Perales‐Puchalt, David B. Weiner
Vaccines (2019) Vol. 7, Iss. 2, pp. 44-44
Open Access | Times Cited: 15
Oncogenic effects of exosomes in γ‐herpesvirus‐associated neoplasms
Jiayu Zheng, Yiwan Shi, Zhenyu Feng, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 11, pp. 19167-19179
Closed Access | Times Cited: 14
Comparative study of FosPeg® photodynamic effect on nasopharyngeal carcinoma cells in 2D and 3D models.
R.W.K. Wu, E.S.M. Chu, John Yuen, et al.
Journal of Photochemistry and Photobiology B Biology (2020) Vol. 210, pp. 111987-111987
Closed Access | Times Cited: 14
Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy
Ivona Nečasová, Martin Stojaspal, Edita Motyčáková, et al.
NAR Cancer (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Withania somniferaextract reduces gastric cancerous properties through inhibition of gankyrin in cellular milieu produced byHelicobacter pyloriand Epstein Barr virus
Dharmendra Kashyap, Rajarshi Roy, Nidhi Varshney, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9399-9415
Closed Access | Times Cited: 4
Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology
Rodney Hull, Rahaba Marima, Mohammed Alaouna, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1448-1448
Open Access | Times Cited: 7
From the midfacial destructive drama to the unfolding EBV story: a short history of EBV-positive NK-cell and T-cell lymphoproliferative diseases
C.S. Ng
Pathology (2024) Vol. 56, Iss. 6, pp. 773-785
Closed Access | Times Cited: 1
Immunometabolism Modulation in Therapy
Ezequiel Monferrer, Sabina Sanegre, Isaac Vieco-Martí, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 798-798
Open Access | Times Cited: 9
The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective
Paul W. Ewald, Holly A. Swain Ewald
Philosophical Transactions of the Royal Society B Biological Sciences (2019) Vol. 374, Iss. 1773, pp. 20180304-20180304
Open Access | Times Cited: 9
Partial absence of PD‐1 expression by tumor‐infiltrating EBV‐specific CD8+ T cells in EBV‐driven lymphoepithelioma‐like carcinoma
Yannick Simoni, Étienne Becht, Shamin Li, et al.
Clinical & Translational Immunology (2020) Vol. 9, Iss. 9
Open Access | Times Cited: 9
Epstein‑Barr virus as a promoter of tumorigenesis in the tumor microenvironment of breast cancer (Review)
José Damián Gómez-Archila, José Arellano‐Galindo, Carmen Palacios‐Reyes, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 2
Open Access | Times Cited: 3
Targeting EBV‐encoded products: Implications for drug development in EBV‐associated diseases
Mengwen Lv, Yuan Ding, Yan Zhang, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 3
Epstein–Barr virus induces morphological and molecular changes in thyroid neoplastic cells
Jacqueline Fátima Martins de Almeida, José Luiz Proença‐Módena, Natássia Elena Búfalo, et al.
Endocrine (2020) Vol. 69, Iss. 2, pp. 321-330
Closed Access | Times Cited: 8
Human Oncogenic Viruses: Old Facts and New Hypotheses
A. V. Bogolyubova
Molecular Biology (2019) Vol. 53, Iss. 5, pp. 767-775
Closed Access | Times Cited: 8
Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis
Saif Zaman, Boris I. Chobrutskiy, Jay S. Patel, et al.
Viral Immunology (2020) Vol. 33, Iss. 5, pp. 404-412
Closed Access | Times Cited: 6
Tumorigenesis and diagnostic practice applied in two oncogenic viruses: Epstein Barr virus and T-cell lymphotropic virus-1—Mini review
Arun Chandra Manivannan, Vinitha Devaraju, Palanivel Velmurugan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111974-111974
Open Access | Times Cited: 6
Epstein–Barr virus infection controls the concentration of the intracellular antioxidant glutathione by upregulation of the glutamate transporter EAAT3 in tumor cells
Gayathri Krishna, Vinod Soman Pillai, Poornima Gopi, et al.
Virus Genes (2022) Vol. 59, Iss. 1, pp. 55-66
Closed Access | Times Cited: 4

Scroll to top